Skip to main content

Retension Pharmaceuticals, Inc.

RTSN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002002988

In the last 90 days, Retension Pharmaceuticals, Inc. insiders filed 2 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Superinvestors holding RTSN, Q2 2026

See all superinvestors

No superinvestor reported holding RTSN in Q2 2026.